Bauer Jake 4/A
4/A · Enliven Therapeutics, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4/AAmended
Bauer Jake
Director
Transactions
- Award
Stock Option (right to buy)
2024-02-13+23,364→ 23,364 totalExercise: $14.85Exp: 2034-02-13→ Common Stock (23,364 underlying)
Footnotes (2)
- [F1]The original Form 4 filed February 15, 2024 incorrectly reported the number of shares subject to the option grant.
- [F2]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.